Lv3
346 积分 2021-03-09 加入
ALK-EML4 Fusion in Small Cell Lung Cancer: Clinical and Molecular Insights From a Rare Case
13小时前
已完结
SMARCA4-deficient Non-small Cell Lung Carcinoma Harboring ALK Fusion
19天前
已完结
Non small cell lung cancer with SMARCA4 deficiency harboring rare EGFR mutations exhibited significant tumor response when treated with afatinib: a case report
19天前
已完结
Acquired SMARCA4 alterations: An uncommon contributor to cancer progression in lung adenocarcinomas
19天前
已完结
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
28天前
已完结
10.1158/1078-0432.CCR-19-1104
28天前
已关闭
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
30天前
已完结
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
30天前
已完结
Immunotherapy may promote the occurrence of radiation-induced brain injury in NSCLC patients with brain metastases undergoing radiotherapy: a retrospective propensity score-matching and inverse probability of treatment weighting study
1个月前
已完结
Effect of adjuvant EGFR-TKI therapy on the prognosis of pathological stage I invasive lung adenocarcinoma with sensitive EGFR mutations
1个月前
已完结
皖公网安备34019202002308
